Search research articles
Contact Us
Filters
Showing results (51-60 of 62) with videos related to
Page
of 7
Sort By:
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience
S Chiara, S Mammoliti, C Oliva, et al.
Oncology
|
January 1, 1989
Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker
M Onetto, M Bruzzone, P F Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer
P F Conte, M Bruzzone, S Chiara, et al.
Cancer Chemotherapy and Pharmacology
|
October 8, 2008
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer
Lorenzo Fornaro, G Masi, S Bursi, et al.
British Journal of Cancer
|
May 14, 2009
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
E Vasile, G Masi, L Fornaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 12, 2005
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
A De Paoli, S Chiara, G Luppi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2008
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer
C Bengala, S Bettelli, F Bertolini, et al.
Anticancer Research
|
May 6, 1998
Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer
M T Nobile, M C Barzacch, O Sanguineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
G Masi, L Salvatore, L Boni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest
P F Conte, M Bruzzone, F Carnino, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 62) with videos related to
Sort By:
Page
of 7
European Journal of Cancer (Oxford, England : 1990)
|
January 1, 1991
Adjuvant cisplatin-based chemotherapy for stage I and II ovarian cancer: a 7-year experience
S Chiara, S Mammoliti, C Oliva, et al.
Oncology
|
January 1, 1989
Evaluation of the ovarian cancer antigen, Ca-125, as a tumor marker
M Onetto, M Bruzzone, P F Conte, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
June 1, 1986
A randomized trial comparing cisplatin plus cyclophosphamide versus cisplatin, doxorubicin, and cyclophosphamide in advanced ovarian cancer
P F Conte, M Bruzzone, S Chiara, et al.
Cancer Chemotherapy and Pharmacology
|
October 8, 2008
A dose finding and pharmacokinetic study of capecitabine in combination with oxaliplatin and irinotecan in metastatic colorectal cancer
Lorenzo Fornaro, G Masi, S Bursi, et al.
British Journal of Cancer
|
May 14, 2009
A multicenter phase II study of the combination of oxaliplatin, irinotecan and capecitabine in the first-line treatment of metastatic colorectal cancer
E Vasile, G Masi, L Fornaro, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
November 12, 2005
Capecitabine in combination with preoperative radiation therapy in locally advanced, resectable, rectal cancer: a multicentric phase II study
A De Paoli, S Chiara, G Luppi, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
December 20, 2008
Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer
C Bengala, S Bettelli, F Bertolini, et al.
Anticancer Research
|
May 6, 1998
Activity of high dose 24 hour 5-fluorouracil infusion plus L-leucovorin in advanced colorectal cancer
M T Nobile, M C Barzacch, O Sanguineti, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
January 21, 2015
Continuation or reintroduction of bevacizumab beyond progression to first-line therapy in metastatic colorectal cancer: final results of the randomized BEBYP trial
G Masi, L Salvatore, L Boni, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 1, 1996
High-dose versus low-dose cisplatin in combination with cyclophosphamide and epidoxorubicin in suboptimal ovarian cancer: a randomized study of the Gruppo Oncologico Nord-Ovest
P F Conte, M Bruzzone, F Carnino, et al.
Page
of 7